Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -9.95%.

  • Rockwell Medical's EBITDA Margin fell 1678.00% to -9.95% in Q3 2025 from the same period last year, while for Sep 2025 it was -6.37%, marking a year-over-year decrease of 695.00%. This contributed to the annual value of 0.60% for FY2024, which is 858.00% up from last year.
  • Per Rockwell Medical's latest filing, its EBITDA Margin stood at -9.95% for Q3 2025, which was down 18.48% from -8.39% recorded in Q2 2025.
  • Rockwell Medical's EBITDA Margin's 5-year high stood at 6.84% during Q3 2024, with a 5-year trough of -54.52% in Q4 2021.
  • For the 3-year period, Rockwell Medical's EBITDA Margin averaged around -5.28%, with its median value being -7.19% (2025).
  • As far as peak fluctuations go, Rockwell Medical's EBITDA Margin spiked by 4,434bps in 2022, and later plummeted by 1,678bps in 2025.
  • Quarterly analysis of 5 years shows Rockwell Medical's EBITDA Margin stood at -54.52% in 2021, then skyrocketed by 4,434bps to -10.18% in 2022, then skyrocketed by 770bps to -2.48% in 2023, then skyrocketed by 37bps to -2.10% in 2024, then tumbled by 1,678bps to -9.95% in 2025.
  • Its last three reported values are -9.95% in Q3 2025, -8.39% for Q2 2025, and -7.19% during Q1 2025.